Literature DB >> 28451649

Objective Measures of Visual Function in Papilledema.

Heather E Moss1.   

Abstract

Visual function is an important parameter to consider when managing patients with papilledema. Though the current standard of care uses standard automated perimetry (SAP) to obtain this information, this test is inherently subjective and prone to patient errors. Objective visual function tests including the visual evoked potential, pattern electroretinogram, photopic negative response of the full field electroretinogram, and pupillary light response have the potential to replace or supplement subjective visual function tests in papilledema management. This article reviews the evidence for use of objective visual function tests to assess visual function in papilledema and discusses future investigations needed to develop them as clinically practical and useful measures for this purpose.

Entities:  

Keywords:  electroretinogram; optic nerve; papilledema; photopic negative response; pupillary light response; retinal ganglion cells; visual evoked potential

Year:  2016        PMID: 28451649      PMCID: PMC5403134          DOI: 10.1016/j.yaoo.2016.03.004

Source DB:  PubMed          Journal:  Adv Ophthalmol Optom


  35 in total

1.  Correlation between N2 amplitude of multifocal ERGs and retinal sensitivity and retinal nerve fiber layer thickness in glaucomatous eyes.

Authors:  Fusae Kato; Gen Miura; Suguru Shirato; Eiju Sato; Shuichi Yamamoto
Journal:  Doc Ophthalmol       Date:  2015-11-02       Impact factor: 2.379

2.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

3.  The photopic negative response of the flash electroretinogram in primary open angle glaucoma.

Authors:  S Viswanathan; L J Frishman; J G Robson; J W Walters
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-02       Impact factor: 4.799

Review 4.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2012-08-01       Impact factor: 21.198

5.  Pattern visual evoked potentials in pseudotumor cerebri. A longitudinal study.

Authors:  P A Rizzo; F Pierelli; G Pozzessere; G Sancesario; M Boatta; G Santarcangelo
Journal:  Acta Neurol Belg       Date:  1984 Mar-Apr       Impact factor: 2.396

6.  The post-illumination pupil response is reduced in glaucoma patients.

Authors:  Laxmikanth Kankipati; Christopher A Girkin; Paul D Gamlin
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-08       Impact factor: 4.799

7.  Visual evoked potentials in pseudotumor cerebri.

Authors:  P S Sørensen; W Trojaborg; F Gjerris; B Krogsaa
Journal:  Arch Neurol       Date:  1985-02

8.  Selective loss of the photopic negative response in patients with optic nerve atrophy.

Authors:  Yasutaka Gotoh; Shigeki Machida; Yutaka Tazawa
Journal:  Arch Ophthalmol       Date:  2004-03

9.  Idiopathic intracranial hypertension and the idiopathic intracranial hypertension treatment trial.

Authors:  Michael Wall
Journal:  J Neuroophthalmol       Date:  2013-03       Impact factor: 3.042

10.  Visual evoked potentials to multiple temporal frequencies. Use in the differential diagnosis of optic neuropathy.

Authors:  P Bobak; R Friedman; M Brigell; J Goodwin; R Anderson
Journal:  Arch Ophthalmol       Date:  1988-07
View more
  3 in total

1.  Gravitational Influence on Intraocular Pressure: Implications for Spaceflight and Disease.

Authors:  Alex S Huang; Michael B Stenger; Brandon R Macias
Journal:  J Glaucoma       Date:  2019-08       Impact factor: 2.503

2.  Diffusion tensor imaging of the optic disc in idiopathic intracranial hypertension?

Authors:  Halil Onder
Journal:  Neuroradiology       Date:  2018-11-28       Impact factor: 2.804

3.  Neuro-ophthalmological manifestations of tuberous sclerosis: current perspectives.

Authors:  Michael J Wan; Ka Lo Chan; Benjamin G Jastrzembski; Asim Ali
Journal:  Eye Brain       Date:  2019-06-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.